Ricardo Rivera-López

Ricardo Rivera-López

Auto-generated profile, based on publicly available information

Ricardo Rivera-López

Servicio de Cardiología, Hospital Universitario Virgen de Las Nieves, Granada, Spain

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JRJorge Rodríguez-Capitán
Jorge Rodríguez-Capitán
ASAndrés Sánchez-Pérez
Andrés Sánchez-Pérez
SBSara Ballesteros-Pradas
Sara Ballesteros-Pradas
MMMercedes Millán-Gómez
Mercedes Millán-Gómez
RPRosa María Cardenal Piris
Rosa María Cardenal Piris
MJManuel Jiménez-Navarro
Manuel Jiménez-Navarro
The clinical significance of non-obstructive coronary artery disease is the subject of debate. Our objective was to evaluate the long-term cardiovascular prognosis associated with non-obstructive coronary artery disease in patients undergoing coronary angiography, and to conduct a stratification by sex, diabetes, and clinical indication. We designed a multi-centre retrospective longitudinal observational study of 3265 patients that were classified into three groups: normal coronary arteries (lesion 70%, 1196 patients). During a mean follow-up of 43 months, we evaluated a combined cardiovascular event: acute myocardial infarction, stroke, hospitalization for heart failure, or cardiovascular death. Multivariable-adjusted Cox proportional hazard models showed a worse prognosis in patients with non-obstructive coronary artery disease, in comparison with patients of normal coronary arteries group, in the total population (hazard ratio 1.72, 95% confidence interval 1.23–2.39; p for trend <0.001), in non-diabetics (hazard ratio 2.12, 95% confidence interval: 1.40–3.22), in women (hazard ratio 1.75, 95% confidence interval 1.10–2.77), and after acute coronary syndrome (hazard ratio 2.07, 95% confidence interval 1.25–3.44). In conclusion, non-obstructive coronary artery disease is associated with an impaired long-term cardiovascular prognosis. This association held for non-diabetics, women, and after acute coronary syndrome.

11 April 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RRRicardo Rivera-López
Ricardo Rivera-López
JJJuan Jiménez-Jáimez
Juan Jiménez-Jáimez
JSJosé Mario Sabio
José Mario Sabio
MZMónica Zamora-Pasadas
Mónica Zamora-Pasadas
JVJosé Antonio Vargas-Hitos
José Antonio Vargas-Hitos
JJJuan Jiménez-Alonso
Juan Jiménez-Alonso
The QT interval on the electrocardiogram has been shown to be longer in patients with systemic lupus erythematosus (SLE) compared to that of the general population. The clinical significance of this finding is unknown. The aim of this study was to assess the relationship between QT interval and subclinical atherosclerosis, measured by carotid-femoral pulse-wave velocity. 93 patients with SLE and 109 healthy women with similar basal characteristics were studied. All patients underwent a 12- lead electrocardiogram, and corrected QT interval (QTc) was measured using the Bazett’s formula. The presence of atherosclerosis was evaluated by carotid-femoral pulse-wave velocity. Clinical basal characteristics were similar in both groups. QTc interval was 415±21.4 milliseconds in all patients, and 407±19.1 milliseconds in the control group (p = 0.007). There was a positive correlation between QTc interval and carotid-femoral pulse-wave velocity (r = 0.235; p = 0.02) in patients with SLE. This association was independent of hypertension and age in a multivariate analysis. QTc interval measured by electrocardiogram is prolonged in SLE patients; it is related to subclinical atherosclerosis, measured by carotid-femoral pulse-wave velocity. This measure may help stratify risk in routine clinical practice and select the patients that might benefit from a more aggressive therapy in the prevention of cardiovascular events.

1 July 2020 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Closed access
LJLaura Jordán-Martínez
Laura Jordán-Martínez
RRRicardo Rivera-López
Ricardo Rivera-López
FBFrancisco José Bermúdez-Jiménez
Francisco José Bermúdez-Jiménez
JJJuan Jiménez Jáimez
Juan Jiménez Jáimez
JAJavier Alzueta
Javier Alzueta
LTLuis Tercedor
Luis Tercedor

29 November 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
MMManuel Mokina-Lerma
Manuel Mokina-Lerma
Eva Cabrera-BorregoEva Cabrera-Borrego
Eva Cabrera-Borrego
RRRicardo Rivera-Lopez
Ricardo Rivera-Lopez
PSPablo Sánchez-Millán
Pablo Sánchez-Millán
JMJesús Peña Mellado
Jesús Peña Mellado
MÁMiguel Álvarez
Miguel Álvarez
The compatibility of cardiac pacing with the presence of a subcutaneous implantable cardioverter-defibrillator (S-ICD) has been investigated, but S-ICD screening test results have not been compared among different pacing sites. The objective was to compare S-ICD screening results among different cardiac pacing sites and to assess the electrocardiographic predictors of success. This prospective single-centre study conducted automated S-ICD screening in 102 carriers of cardiac pacing devices in conduction system (CSP), biventricular (BVP), right ventricular outflow tract (RVOT), or right ventricular apex (RVA) pacing sites. The study included 102 patients: 40 with CSP (20 left bundle pacing and 20 His bundle pacing), 21 with BVP, and 20 and 21 with RVOT and RVA pacing, respectively. The percentage of positive screenings was significantly higher for CSP (97.5%) than for the other patient groups (BVP 71.4%, RVOT 70%, and RVA 19%). In multivariate analysis, positive screening was associated with a narrower QRS (OR 0.95 [0.92–0.98] P = 0.001) and higher R/T ratio in precordial leads (1.76 [1.18–2.61]). A higher S-ICD eligibility rate of cardiac pacing device carriers was obtained in CSP than in conventional pacing (RVA or RVOT) or BVP. The presence of narrower paced QRS width and paced corrected QT interval and of higher R/T ratio in precordial and limb leads are electrocardiographic predictors of a positive response to screening. (A) Electrocardiographic predictors related to positive screening. (B) Multivariate logistic regression analysis with ‘positive screening’ as dependent variable. (C) Multivariate logistic regression analysis with ‘positive screening’ as dependent variable including ‘pacing site’ variable. **RV apex as reference value. OR, odds ratio; CSP, conduction system pacing; BVP, biventricular pacing; RVOT, right ventricular outflow tract; pQTc, paced corrected QT interval; R/Tp, T and R wave ratio in precordial leads; R/TL, T and R wave ratio in limb leads.

1 December 2021 in Medicina Clínica (English Edition)
Verified
Journal Article
Closed access
JRJavier Ramos-Maqueda
Javier Ramos-Maqueda
CNCristina Navarro-Valverde
Cristina Navarro-Valverde
IEIrene Esteve-Ruiz
Irene Esteve-Ruiz
MCMercedes Cabrera-Ramos
Mercedes Cabrera-Ramos
RRRicardo Rivera-López
Ricardo Rivera-López
FMFrancisco Javier Molano-Casimiro
Francisco Javier Molano-Casimiro

1 May 2018 in Medicina Clinica
Verified
Journal Article
Closed access
RRRicardo Rivera-López
Ricardo Rivera-López
LJLaura Jordán-Martínez
Laura Jordán-Martínez
SLSilvia López-Fernández
Silvia López-Fernández
RRRicardo Rivera-Fernández
Ricardo Rivera-Fernández
LTLuis Tercedor
Luis Tercedor
GSGermán Sáez-Roca
Germán Sáez-Roca